Annexon Biosciences
Develops therapies for complement-mediated neuroinflammatory and autoimmune diseases.
Company facts
- Founded
- 2011
- Employees
- 118
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ANNX
- Subsidiaries
- Annexon Biosciences Australia Pty Ltd